Nuveen Fund Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-8,562
| Closed | -$409K | – | 14 |
|
2018
Q4 | $409K | Sell |
8,562
-10,924
| -56% | -$522K | 3.63% | 6 |
|
2018
Q3 | $978K | Sell |
19,486
-8,036
| -29% | -$403K | 2.17% | 5 |
|
2018
Q2 | $1.39M | Sell |
27,522
-10,204
| -27% | -$514K | 1.71% | 5 |
|
2018
Q1 | $1.84M | Sell |
37,726
-5,644
| -13% | -$276K | 0.85% | 32 |
|
2017
Q4 | $1.92M | Sell |
43,370
-6,820
| -14% | -$302K | 0.56% | 45 |
|
2017
Q3 | $2.55M | Sell |
50,190
-5,175
| -9% | -$263K | 0.52% | 50 |
|
2017
Q2 | $2.93M | Sell |
55,365
-1,067
| -2% | -$56.4K | 0.47% | 59 |
|
2017
Q1 | $2.95M | Buy |
56,432
+13,082
| +30% | +$685K | 0.39% | 88 |
|
2016
Q4 | $2.09M | Buy |
43,350
+11,753
| +37% | +$566K | 0.3% | 115 |
|
2016
Q3 | $1.7M | Buy |
31,597
+3,991
| +14% | +$215K | 0.24% | 142 |
|
2016
Q2 | $1.5M | Buy |
+27,606
| New | +$1.5M | 0.23% | 126 |
|